-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, APQW2KnjaWRqhlqEJRGedLnEYmWLC058bPy0eOqFSuuKR3OBr+l7gL5y7nBkWT2/ VZ2tjfj8o3CxMonosS3OPQ== 0001193125-03-030960.txt : 20030807 0001193125-03-030960.hdr.sgml : 20030807 20030807164022 ACCESSION NUMBER: 0001193125-03-030960 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030807 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 03829120 BUSINESS ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 8-K 1 d8k.htm FORM 8-K Form 8-K

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): August 7, 2003

 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

0-24260   11-3131700
(Commission File Number)  

(I.R.S.  Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 



ITEM 5.    OTHER EVENTS

 

On August 7, 2003, Amedisys, Inc., “the Company” issued a press release attached hereto as Exhibit 99.1 to announce that it has purchased two home care agencies in southeast Louisiana.

 

ITEM 7.    FINANCIAL STATEMENTS AND EXHIBITS

 

(a)    Financial Statements of Business Acquired.

 

Not applicable.

 

(b)    Pro Forma Financial Information.

 

Not applicable.

 

(c)    

 

Exhibit

No.


      
99.1 (i)    Press Release dated August 7, 2003 announcing purchase of two home care agencies in southeast Louisiana
  (i) Filed herewith.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.

By:

 

/s/ Gregory H. Browne


Gregory H. Browne

Chief Financial Officer

 

DATE: August 7, 2003

 

2

EX-99.1 3 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

AMEDISYS ACQUIRES HOME CARE AGENCIES

 

ACQUISITION OF HOME CARE OPERATIONS ALLOWS COMPANY TO

INCREASE MARKET PRESENCE IN SOUTHEAST LOUISIANA

 

BATON ROUGE, Louisiana (August 7, 2003) – Amedisys, Inc. (Nasdaq: “AMED” or “the Company”), one of America’s leading home health nursing companies, today announced that it has purchased two home care agencies trading under the name Metro Home Health. The purchase price was approximately $8 million.

 

The agencies operate in the suburban areas of Southeast Louisiana, including the greater New Orleans metropolitan area. Louisiana is one of the eleven states in the southeastern U.S. where Amedisys is a leading provider of home nursing care.

 

“We are very pleased to complete this acquisition, which will allow us to increase our market presence in this area,” stated William F. Borne, Chairman and Chief Executive Officer of Amedisys, Inc. “The addition of Metro, and its highly regarded management team, will allow Amedisys, Inc. the opportunity to dominate this market.”

 

“The newly acquired agencies in Louisiana should contribute $17 million to $18 million to our annualized revenues, and should be accretive to net income by $0.03 to $0.04 in 2003, and by $0.07 to $0.10 in 2004,” continued Mr. Borne.

 

“The purchase price comprised of $6 million in cash at closing, $1 million in a three-year note subject to performance requirements, and 163,000 shares of Amedisys, Inc. common stock, subject to one year restriction on sales. The Company funded the transaction without recourse to external finance sources, as Cash and Cash Equivalents totaled over $12 million at June 30, 2003.”

 

The Company also announced that it completed a smaller acquisition effective July 1, 2003. This acquisition, of an agency operating in the market surrounding Fort Smith, Arkansas, complements the Company’s existing operations in eastern Oklahoma. The agency was acquired from Van Buren H.M.A. Inc., and marks the Company’s entry into the State of Arkansas.

 

“Amedisys intends to continue executing its strategy of pursuing external growth opportunities in the current environment,” concluded Mr. Borne.

 

Further information will be provided on the teleconference call scheduled for August 12, 2003 at 10:00 a.m. ET.

 

Amedisys, Inc., a leading provider of home health nursing services, is headquartered in Baton Rouge, Louisiana. The Company had approximately $129 million in revenue in 2002. Its common stock trades on the Nasdaq Stock Market under the symbol “AMED”.


This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe”, “estimate”, “project”, “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products and services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company’s periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

 

Additional information on this Company can be found on the World Wide Web

 

http://www.amedisys.com

 

Contact:  

Amedisys, Inc.

 

EURO RSCG Life NRP

   

Chief Financial Officer

 

Investors/Media

   

Greg Browne

 

John Capodanno

   

225.292.2031

 

212.845.4258

   

gbrowne@amedisys.com

 

john.capodanno@nrp-euro.com

 

-----END PRIVACY-ENHANCED MESSAGE-----